P. Platzer

发表

SNP arrays in heterogeneous tissue: highly accurate collection of both germline and somatic genetic information from unpaired single tumor samples.

T. LaFramboise, J. Bertherat, G. Assié, 2008, American journal of human genetics.

15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis

T. P. Pretlow, R. Rerko, J. Willis, 2006, Proceedings of the National Academy of Sciences.

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.

J. Lutterbaugh, R. Rerko, J. Willis, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.

P. Platzer, R. Kaufman, D. Ginsburg, 2008, Blood.

factor VIII Genotype-phenotype correlation in combined deficiency of factor V and

P. Platzer, R. Kaufman, J. Mahlangu, 2011 .

Breast-cancer stromal cells with TP53 mutations and nodal metastases.

P. Platzer, C. Eng, Yaomin Xu, 2007, The New England journal of medicine.

PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.

J. Lutterbaugh, R. Rerko, J. Willis, 2003, Cancer research.

Silence of chromosomal amplifications in colon cancer.

Keith Wilson, Thomas Ried, Joseph Willis, 2002, Cancer research.

Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

L. Myeroff, T. P. Pretlow, L. Kasturi, 2005, Journal of the National Cancer Institute.

Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival

Jill S Barnholtz-Sloan, Nathan Morris, Joseph Willis, 2015, Oncotarget.

A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2

R. Elston, J. Lutterbaugh, J. Willis, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Ugene, a newly identified protein that is commonly overexpressed in cancer and binds uracil DNA glycosylase.

J. Willson, S. Markowitz, P. Platzer, 2008, Cancer research.

Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma.

P. Platzer, C. Eng, Yaomin Xu, 2007, JAMA.

Frequency of germline genomic homozygosity associated with cancer cases.

Thomas LaFramboise, Charis Eng, T. LaFramboise, 2008, JAMA.

Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.

Charis Eng, Kristin A Waite, P. Platzer, 2008, American journal of human genetics.

Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study.

R. Elston, J. Willis, S. Markowitz, 2008, American journal of human genetics.

Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome.

P. Platzer, C. Eng, K. Waite, 2008, American journal of human genetics.

Testing for colon neoplasia susceptibility variants at the human COX2 locus.

R. Elston, A. Chakravarti, J. Willis, 2001, Journal of the National Cancer Institute.

Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of colon neoplasia

Keith Wilson, Sanford Markowitz, J. Willson, 2005, Oncogene.